Top

Cancer Causes & Control

Published in:

01-03-2011 | Brief report

Reduction of hepatocellular carcinoma in childhood after introduction of selective vaccination against hepatitis B virus for infants born to HBV carrier mothers

Authors: Hitoshi Tajiri, Hideo Tanaka, Stephen Brooks, Tomoko Takano

Published in: Cancer Causes & Control | Issue 3/2011

Abstract

Objective

A nation-wide prevention program utilizing passive-active immunoprophylaxis for high-risk babies against maternal HBV transmission was introduced in Japan in January of 1986. The prevention program was expected to eradicate HBV-related hepatocellular carcinoma (HCC). The aim of this study was to evaluate the effect of this selective prevention program against maternal HBV transmission on the occurrence of HBV-related HCC.

Methods

We reviewed the annual reports from a nation-wide survey of childhood solid tumors that was reported in the Journal of the Japanese Society of Pediatric Surgeons during the 28 years period from 1981 to 2008. The number of HCC cases were grouped for every 5-year period with an additional period of the past 3 years and compared with those of hepatoblastoma.

Results

The reported number of children with hepatoblastoma in each period was constant during the 28 years study period. In contrast, both the number of patients with HBV-related HCC and the ratio of HBV-related HCC to hepatoblastoma gradually decreased over the study period, with a significant drop in the last two periods ranging from 2001 to 2008 (p < 0.001).

Conclusion

The prevention program against maternal HBV infection of infants born to HBV carrier mothers may have decreased the occurrence of HBV-related HCC in childhood.

Yeung YP, Lo CM, Liu CL, Wong BC, Fan ST, Wong J (2005) Natural history of untreated nonsurgical hepatocellular carcinoma. Am J Gastroenterol 100:1995–2004CrossRefPubMed

Chang MH, Chen DS, Hsu HC, Hsu HY, Lee CY (1989) Maternal transmission of hepatitis B virus in childhood hepatocellular carcinoma. Cancer 64:2377–2380CrossRefPubMed

Koyama T, Matsuda I, Sato S, Yoshizawa H (2003) Prevention of perinatal hepatitis B virus transmission by combined passive-active immunoprophylaxis in Iwate, Japan (1981–1992) and epidemiological evidence for its efficacy. Hepatol Res 26:287–292CrossRefPubMed

Tanimura M, Matsui I, Abe J et al (1998) Increased risk of hepatoblastoma among immature children with a lower birth weight. Cancer Res 58:3032–3035PubMed

Mann JR, Kasthuri N, Raafat F et al (1990) Malignant hepatic tumors in children: incidence, clinical features and aetiology. Paediatr Perinat Epidemiol 4:276–289CrossRefPubMed

Matsuda T, Marugame T, Kamo K et al (2009) Cancer incidence and incidence rates in Japan in 2003: based on data from 13 population-based cancer registries in the monitoring of cancer incidence in Japan (MCIJ) project. Jpn J Clin Oncol 39:850–858CrossRefPubMed

Ramsay M, Gay N, Balogun K, Collins M (1998) Control of hepatitis B in the United Kingdom. Vaccine 16 Suppl:S52–S55CrossRefPubMed

Noto H, Terao T, Ryou S et al (2003) Combined passive and active immunoprophylaxis for preventing perinatal transmission of the hepatitis B virus carrier state in Shizuoka, Japan during 1980–1994. J Gastroenterol Hepatol 18:943–949CrossRefPubMed

Yoshikawa A, Suzuki K, Abe A et al (2009) Effect of selective vaccination on a decrease in the rate of hepatitis B virus-positive Japanese first-time blood donors. Transfus Med 19:172–179CrossRefPubMed

10.

Chang MH, Chen CJ, Lai MS et al (1997) Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan childhood hepatoma study group. N Engl J Med 336:1855–1859CrossRefPubMed

11.

Chang MH, Shau WY, Chen CJ et al (2000) Hepatitis B vaccination and hepatocellular carcinoma rates in boys and girls. JAMA 284:3040–3042CrossRefPubMed

12.

Chang MH, You SL, Chen CJ et al (2009) Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20 year follow-up study. J Natl Cancer Inst 101:1348–1355CrossRefPubMed

13.

Chang MH, Chen TH, Hsu HM et al (2005) Prevention of hepatocellular carcinoma by universal vaccination against hepatitis B virus: the effect and problems. Clin Cancer Res 11:7953–7957CrossRefPubMed

14.

Lack EE, Neave C, Vawter GF (1982) Hepatoblastoma. A clinical and pathologic study of 54 cases. Am J Surg Pathol 6:693–705CrossRefPubMed

15.

Sasaki F, Matsunaga T, Iwafuchi M et al (2002) Outcome of hepatoblastoma treated with the JPLT-1 (japanese study group for pediatric liver tumor) protocol-1: a report from the Japanese study group for pediatric liver tumor. J Pediatr Surg 37:851–856CrossRefPubMed

Title: Reduction of hepatocellular carcinoma in childhood after introduction of selective vaccination against hepatitis B virus for infants born to HBV carrier mothers
Authors: Hitoshi Tajiri
Hideo Tanaka
Stephen Brooks
Tomoko Takano
Publication date: 01-03-2011
Publisher: Springer Netherlands
Published in: Cancer Causes & Control / Issue 3/2011
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI: https://doi.org/10.1007/s10552-010-9721-4

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Objective

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 3/2011

Coffee consumption and reduced risk of hepatocellular carcinoma: findings from the Singapore Chinese Health Study

Helicobacter pylori infection and gastric cardia cancer: systematic review and meta-analysis

The associations between statin use and prostate cancer screening, prostate size, high-grade prostatic intraepithelial neoplasia (PIN), and prostate cancer

Inequity in access to cancer care: a review of the Canadian literature

Has the lung cancer risk from smoking increased over the last fifty years?

A review of African American-white differences in risk factors for cancer: prostate cancer

Keynote webinar | Spotlight on antibody–drug conjugates in cancer